Laser Photonics (NASDAQ:LASE) closed the cash exercise of warrants issued September 2025, raising approximately $1.5 million in gross proceeds at a reduced exercise price of $1.08 per share (originally $3.40).
The company issued new unregistered Series A-3 and A-4 warrants, will file a resale registration statement, and intends to use net proceeds for working capital and general corporate purposes.
Loading...
Loading translation...
Positive
Gross proceeds of approximately $1.5 million
Underlying shares registered via effective Form S-1 (No. 333-290875)
Proceeds earmarked for working capital and general corporate purposes
Negative
Immediate dilution: 1,373,630 shares issued upon warrant exercise
Additional dilution potential: up to 2,747,260 shares from new Series A-3 and A-4 warrants
Exercise price reduced from $3.40 to $1.08 per share
News Market Reaction – LASE
-6.76%
3 alerts
-6.76%Session close to close
$27.23MMarket Cap
0.1xRel. Volume
In the Mar 18 session, LASE declined 6.76%, reflecting a notable negative market reaction.
Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.
The stock moved -6.8% in the session following this news. A negative reaction despite the cash inflo...
Analysis
The stock moved -6.8% in the session following this news. A negative reaction despite the cash inflow would fit prior offering patterns, where similar financings averaged -28.2% moves. This announcement confirms a reduced exercise price of $1.08 and issuance of new Series A-3 and A-4 warrants totaling 2,747,260 shares, adding potential dilution. Investors have previously treated such structures warily, so continued sensitivity to equity‑linked funding remained a key risk factor.
Key Figures
Gross proceeds:$1.5 millionWarrants exercised:1,373,630 sharesOriginal exercise price:$3.40 per share+5 more
8 metrics
Gross proceeds$1.5 millionWarrant exercise gross proceeds before fees
$5.0M public offering of shares with warrants at $0.70 per unit.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Prior capital-raising and warrant-related offerings have been followed by notably negative reactions, with an average move of -28.2% across similar events.
Recent Company History
Over recent months, Laser Photonics has repeatedly tapped equity markets via offerings and warrant structures. An offering on February 6, 2026 for about $5.0 million and a warrant exercise agreement on March 16, 2026 each coincided with double‑digit percentage declines. Today’s closing of the previously announced warrant exercise continues that capital-raising pattern, using similar agents and structures and again earmarking proceeds for working capital and general corporate purposes.
Key Terms
warrants, registration statement, form s-1, placement agent, +2 more
6 terms
warrantsfinancial
"exercise of certain outstanding warrants to purchase up to an aggregate of 1,373,630 shares"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
"registered pursuant to an effective registration statement on Form S-1 (No. 333-290875)"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.
form s-1regulatory
"registered pursuant to an effective registration statement on Form S-1 (No. 333-290875)"
A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.
placement agentfinancial
"H.C. Wainwright & Co. acted as the exclusive placement agent for the offering."
A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.
private placementfinancial
"The new warrants described above were offered in a private placement pursuant to an applicable exemption"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
resale registration statementregulatory
"file a registration statement with the SEC covering the resale of the shares ... (the "Resale Registration Statement")"
A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.
ORLANDO, FL / ACCESS Newswire / March 17, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a global leader in laser systems for industrial and defense applications, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 1,373,630 shares of common stock of the Company originally issued in September 2025, having an exercise price of $3.40 per share, at a reduced exercise price of $1.08 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-290875). The gross proceeds to the Company from the exercise of the warrants were approximately $1.5 million, prior to deducting placement agent fees and estimated offering expenses.
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
In consideration for the immediate exercise of the warrants for cash, the Company issued new unregistered Series A-3 warrants to purchase up to 1,373,630 shares of common stock and new unregistered Series A-4 warrants to purchase up to 1,373,630 shares of common stock. The new warrants have an exercise price of $1.08 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the new warrants. The Series A-3 new warrants will expire five years after the later of (i) the date of stockholder approval and (ii) the effective date of the Resale Registration Statement (as defined below) and the Series A-4 new warrants will expire eighteen months after the later of (x) the date of stockholder approval and (y) the effective date of the Resale Registration Statement.
The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "1933 Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").
This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Laser Photonics Corporation Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit https://laserphotonics.com.
Cautionary Note Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the receipt of stockholder approval and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption "Risk Factors" in our Form 10-K for the fiscal year ended December 31, 2024. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.
Investor Relations Contact: Lucas A. Zimmerman & Ian Scargill MZ Group - MZ North America (262) 357-2918 LASE@mzgroup.us www.mzgroup.us
How much cash did Laser Photonics (LASE) raise from the warrant exercises on March 17, 2026?
Laser Photonics raised approximately $1.5 million in gross proceeds from the warrant exercises. According to the company, that amount is before placement agent fees and estimated offering expenses, and will be used for working capital and general corporate purposes.
What was the exercise price for the warrants Laser Photonics (LASE) closed on March 17, 2026?
The exercised warrants had an effective exercise price of $1.08 per share after reduction. According to the company, the warrants were originally issued at a $3.40 exercise price in September 2025 and were cash-exercised at the reduced price.
What new warrants did Laser Photonics (LASE) issue after the March 17, 2026 closing?
The company issued new unregistered Series A-3 and Series A-4 warrants, each covering up to 1,373,630 shares. According to the company, Series A-3 expire five years after approval and Series A-4 expire eighteen months after approval, subject to registration timing.
Will the shares from Laser Photonics (LASE) warrant exercises be registered for resale?
Yes, the shares issuable upon exercise are registered under an effective Form S-1 and the company agreed to file a resale registration statement. According to the company, resale registration timing depends on SEC filing and stockholder approval where required.
How might the March 17, 2026 warrant transactions affect LASE shareholders?
Shareholders face dilution risk from issued and potential warrants totaling up to 4,121,520 shares including exercised and new warrants. According to the company, issued shares plus two sets of new warrants could increase outstanding shares if exercised.